Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

24.00EUR
7:55am EDT
Change (% chg)

€0.11 (+0.46%)
Prev Close
€23.89
Open
€23.86
Day's High
€24.10
Day's Low
€23.85
Volume
126,562
Avg. Vol
673,745
52-wk High
€28.07
52-wk Low
€21.50

Latest Key Developments (Source: Significant Developments)

Grifols Obtains 85 Mln Euro Loan From EIB
Friday, 7 Sep 2018 05:47am EDT 

Sept 7 (Reuters) - Grifols SA ::SAYS OBTAINED NEW LONG-TERM LOAN WITH EUROPEAN INVESTMENT BANK (EIB) TOTALING 85 MILLION EUROS.SAYS CONDITIONS INCLUDE FIXED INTEREST RATE OVER 10 YEARS AND TWO-YEAR GRACE PERIOD.  Full Article

Grifols Receives FDA Approval For New Manufacturing Facility For Production Of Recombinant Proteins
Thursday, 16 Aug 2018 08:00am EDT 

Aug 16 (Reuters) - Grifols SA ::GRIFOLS ACHIEVES KEY MILESTONE WITH FDA APPROVAL OF THE NEW CONSOLIDATED MANUFACTURING FACILITY (CMF) FOR PRODUCTION OF RECOMBINANT PROTEINS.  Full Article

Grifols Announces New Agreement With Henry Schein To Distribute Normal Saline Solution In U.S.
Monday, 5 Mar 2018 09:00am EST 

March 5 (Reuters) - Grifols Sa ::GRIFOLS - ANNOUNCES NEW AGREEMENT WITH HENRY SCHEIN TO DISTRIBUTE NORMAL SALINE SOLUTION IN THE U.S..GRIFOLS - IN 2018, GRIFOLS WILL CONTINUE EXPANSION OF ITS CAPACITY IN ITS INDUSTRIAL COMPLEX IN BARCELONA.GRIFOLS - ‍EXPANSION INCLUDES 2 NEW PRODUCTION LINES OF IV SOLUTIONS, ENABLING BARCELONA PLANT TO ADD PRODUCTION CAPACITY BY 20 MILLION UNITS​.  Full Article

Grifols FY Net Profit Up At 662.7 Mln Euros
Wednesday, 28 Feb 2018 02:27am EST 

Feb 28 (Reuters) - Grifols ::FY NET SALES 4.32 BILLION EUROS VERSUS 4.05 BILLION EUROS YEAR AGO.FY NET PROFIT 662.7 MILLION EUROS VERSUS 545.5 MILLION EUROS YEAR AGO.  Full Article

Grifols Receives FDA Approval For New Formulation Of Its Rabies Virus Treatment
Tuesday, 6 Feb 2018 09:45am EST 

Feb 6 (Reuters) - Grifols SA ::GRIFOLS HYPERRAB® (RABIES IMMUNE GLOBULIN HUMAN) 300 IU/ML RECEIVES FDA APPROVAL TO TREAT PATIENTS EXPOSED TO RABIES VIRUS INFECTION.  Full Article

Grifols Buys 51 Pct Of Medkeeper
Friday, 26 Jan 2018 02:28am EST 

Jan 26 (Reuters) - GRIFOLS SA ::BUYS 51 PERCENT SHARE CAPITAL IN MEDKEEPER.SAYS PURCHASE RESULT OF $98 MLN CAPITAL INCREASE IN MEDKEEPER.NEGOTIATED CALL OPTION TO ACQUIRE REMAINING 49 PERCENT INTEREST EXERCISABLE DURING 3 YEAR PERIOD.  Full Article

Grifols says FDA approves genetic test and EMA biological sealant
Friday, 17 Nov 2017 11:32am EST 

Nov 17 (Reuters) - GRIFOLS SA ::GETS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS NEW GENETIC TEST TO DETECT ALPHA-1 ANTITRYPSIN DEFICIENCY‍​.THE EUROPEAN MEDICINES AGENCY (EMA) APPROVES NEW PRODUCT, BIOLOGICAL SEALANT, TO USE IN SURGICAL OPERATIONS IN ADULTS.‍​.  Full Article

Grifols gets approval from US FDA for new product
Monday, 6 Nov 2017 02:25am EST 

Nov 6 (Reuters) - GRIFOLS SA ::EARNS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR NEW PRODUCT FIBRIN SEALANT (HUMAN) COMPOSED OF TWO PLASMA PROTEINS AND INDICATED FOR SURGICAL USE IN ADULTS.‍​.  Full Article

Grifols 9-month net profit up 6.3 pct at 431.8 mln euros YoY
Thursday, 2 Nov 2017 03:22am EDT 

Nov 2 (Reuters) - GRIFOLS SA ::9-MONTH NET PROFIT 431.8 MILLION EUROS VERSUS 406.1 MILLION EUROS YEAR AGO.9-MONTH NET SALES 3.25 BILLION EUROS VERSUS 2.95 BILLION EUROS YEAR AGO.9-MONTH EBITDA 960.9 MILLION EUROS VERSUS 842.9 MILLION EUROS YEAR AGO.  Full Article

Grifols approves interim dividend of 0.18 eur/shr
Monday, 30 Oct 2017 03:18am EDT 

Oct 30 (Reuters) - GRIFOLS SA ::APPROVES INTERIM DIVIDEND OF 0.18 EURO PER SHARE PAYABLE DECEMBER 5‍​.  Full Article

Healthcare firm Grifols S.A. wins U.S. antitrust nod to buy Biotest US Corp

WASHINGTON Global healthcare company, Grifols S.A. , which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.